Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NBN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BICD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADCK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C10orf113 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CREM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZYX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF768 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HPF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLEKHG3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RIOK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAND1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF33B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP104 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FLNA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MINOS1P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on